Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 917, doi. 10.1007/s40261-021-01080-z
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 10
Results: 10
1
2
Correction to: Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
3
Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 907, doi. 10.1007/s40261-021-01079-6
- By:
- Publication type:
- Article
4
Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 895, doi. 10.1007/s40261-021-01078-7
- By:
- Publication type:
- Article
5
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 885, doi. 10.1007/s40261-021-01077-8
- By:
- Publication type:
- Article
6
Bempedoic Acid: A New Non-statin Drug for the Treatment of Dyslipidemia.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 843, doi. 10.1007/s40261-021-01075-w
- By:
- Publication type:
- Article
7
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 875, doi. 10.1007/s40261-021-01074-x
- By:
- Publication type:
- Article
8
Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study 'TOPICS Greece'.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 865, doi. 10.1007/s40261-021-01073-y
- By:
- Publication type:
- Article
9
Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 835, doi. 10.1007/s40261-021-01072-z
- By:
- Publication type:
- Article
10
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 10, p. 853, doi. 10.1007/s40261-021-01060-3
- By:
- Publication type:
- Article